February 20, 2019
Post-traumatic stress disorder (PTSD) by itself does not explain the increased risk of cardiovascular disease in veterans with this condition. A combination of physical disorders, psychiatric disorders and smoking, that are more common in patients with PTSD, may explain the association, according to new research in Journal of the American Heart Association.
February 19, 2019
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable cardiac devices.
February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association’s journal Circulation.1
February 05, 2019
Stroke survivors have better quality of life three months after their stroke if the clot that caused the stroke was mechanically removed even hours beyond the ideal treatment window compared to those treated with drugs alone. This preliminary research will be presented, Feb. 6-8 in Honolulu at the American Stroke Association’s International Stroke Conference 2019.
February 04, 2019
Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform. The new flagship platform of systems incorporates all-new features that enable clinicians to deliver images with clarity and precision without compromising workflow and while prioritizing low dose.
February 01, 2019
Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2019.
January 23, 2019
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 annual meeting March 16-18, 2019, in New Orleans. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
January 22, 2019
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined rapidly after several large trials showed no benefit.
January 16, 2019
Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry to collect and analyze stroke-inducing blood clots removed from the brain with its Embotrap II Revascularization Device.
January 15, 2019
Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world.